Status:

RECRUITING

Analgesic Effect of Accelerated Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain

Lead Sponsor:

Jakub Antczak

Conditions:

Peripheral Neuropathy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Peripheral neuropathy is a frequent condition, commonly associated with pain. Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive method of modulation of brain plasticity and is regar...

Detailed Description

Peripheral neuropathy is a frequent condition, commonly associated with pain, which is often drug resistant. Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive method of modulation o...

Eligibility Criteria

Inclusion

  • Diagnosis of peripheral neuropathy
  • Neuropathic pain of constant severity since not less than a month and requiring use of analgesics more than once a week
  • Score of 30 millimeter or more on the 100 millimeter visual analog scale of pain intensity at inclusion

Exclusion

  • Severe depression
  • Personality disorders and other psychiatric conditions, which could disturb the participation in the study
  • Cognitive deficits, which could disturb the participation in the study
  • Epilepsy
  • Presence of magnetic material in the reach of magnetic field
  • Pregnancy
  • Likelihood to get pregnant
  • Intracranial electrodes

Key Trial Info

Start Date :

November 4 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT05295498

Start Date

November 4 2022

End Date

September 30 2026

Last Update

October 10 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Jagiellonian University Medical College

Krakow, Poland, 31008